Antimicrobial Hospital Textiles Global Market Report 2024

The global antimicrobial hospital textiles market has grown strongly in recent years. It will grow from $10 billion in 2023 to $10.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. The growth observed in the historical period can be attributed to several factors, including stringent healthcare regulations, a heightened focus on patient safety, compliance with hospital accreditation requirements, increased investments in research and development within the healthcare sector, and awareness programs aimed at improving healthcare practices and standards.

The global antimicrobial hospital textiles market is expected to see strong growth in the next few years. It will grow to $14.92 billion in 2028 at a compound annual growth rate (CAGR) of 8.5%. The anticipated growth in the forecast period is driven by factors such as global health crises, a surge in healthcare infrastructure development, a growing demand for sustainable and eco-friendly textiles, the rising geriatric population, government initiatives promoting healthcare hygiene, and heightened awareness of textile-related infections. Key trends expected in the forecast period include a heightened focus on infection control, advancements in antimicrobial technologies, an increased demand for sustainable antimicrobial textiles, the integration of smart textile technologies, and a rising trend of collaborations and partnerships within the industry.

The surge in consciousness about hospital-acquired infections is anticipated to drive the growth of the market for antimicrobial hospital textiles in the coming years. These infections occur within healthcare facilities and are contracted from healthcare providers, impacting various bodily systems. Antimicrobial hospital textiles play a pivotal role in curbing these infections by employing substances that inhibit the growth and spread of bacteria, thereby reducing the risk of infections in medical settings. For instance, according to September 2021 data from the National Healthcare Safety Network (NHSN), catheter-associated urinary tract infections and Methicillin-resistant Staphylococcus aureus (MRSA) infections in the US surged by 18.8% and 33.8%, respectively, in the fourth quarter of 2020 compared to 2019. Significant increases in MRSA, Central Line-Associated Bloodstream Infections (CLABSI), and Catheter-Associated Urinary Tract Infections (CAUTI) were reported between 2020 and 2021, underscoring the need for antimicrobial hospital textiles to combat such infections.

The growth of the antimicrobial hospital textiles market is expected to be propelled by the aging population. With an increasing proportion of elderly individuals within societies, antimicrobial hospital textiles are critical for infection control in this demographic. These textiles act as a protective barrier against pathogens, addressing infection-related concerns prevalent in healthcare settings serving the aging population. As projected by the World Health Organization in October 2022, by 2030, one in every six individuals globally will be 60 years or older, and this proportion is expected to rise to 1.4 billion people. Additionally, by 2050, the number of individuals aged 60 and above is projected to double to 2.1 billion, emphasizing the growing significance of antimicrobial textiles in healthcare facilities catering to this demographic.

Leading companies in the antimicrobial hospital textiles market are introducing sustainable antimicrobial fabric to meet escalating market demands. Sustainable antimicrobial fabric refers to textiles manufactured through environmentally conscious processes and materials, equipped with antimicrobial properties that combat microorganisms while minimizing environmental impact. For instance, in October 2022, Noble Biomaterials unveiled Ionic+ Botanical, an innovative antimicrobial fabric treatment utilizing renewable citric-based technology. This solution offers durability for up to 50 wash cycles and complements Noble's existing Ionic+ Mineral technology. The company collaborates with partners such as Salomon, Crystal Denim, and Trident to extend the application of Ionic+ products across various sectors like home textiles, luggage, and sports accessories, emphasizing sustainability and efficacy in antimicrobial fabric development.

Prominent companies in the antimicrobial hospital textiles sector are introducing novel solutions, particularly antimicrobial curtains tailored for healthcare settings. These specialized curtains are designed with materials or coatings that hinder microorganism growth, establishing a hygienic barrier to mitigate contamination risks in sensitive environments like healthcare facilities. For instance, in May 2022, Sereneview Armor, a US-based healthcare design firm, introduced Sereneview Armor curtains featuring Aegis Microbe Shield, a robust, non-leaching antimicrobial technology. The curtains incorporate a positively charged polymer that disrupts the negatively charged cell membranes of microbes, aiming to prevent hospital-acquired infections. Testing of the Armor fabric against the SARS-COVID-2 virus revealed promising results, demonstrating its efficacy compared to a control fabric lacking similar finishes.

In a strategic move to expand its foothold in the bio-based antimicrobial sector, HeiQ, a Switzerland-based chemical manufacturer, acquired Life Material Technologies Limited in June 2021, augmenting its position and product portfolio. The acquisition enables HeiQ to strengthen its presence in the healthcare surface hygiene markets and bolster its innovation capabilities, positioning the company as a leading innovator in materials technology. Life Material Technologies Limited, headquartered in Bangkok, specializes in the development of antimicrobial hospital textiles, complementing HeiQ's strategic objectives in this sector.

Major companies operating in the antimicrobial hospital textiles market report are Sinterama S.p.A., Trevira GmbH, PurThread Technologies Inc., LifeThreads LLC, Thai Acrylic Fiber Co. Ltd., Smith & Nephew PLC, Herculite Products Inc., Toyobo Co. Ltd., Mollyflex Srl, Swicofil AG, Baltex Group Limited, Microban International Ltd., Sciessent LLC, BASF SE, Lonza Group AG, BioCote Limited, Resil Chemicals Pvt. Ltd., Archroma Management LLC, HeiQ Materials AG, Milliken & Company, Vestagen Technical Textiles Inc., Bovie Medical Corporation, Copper Clothing Ltd., The Medicom Group, Foothills Industries Ltd., Resweater, Specialty Textile Group Inc., Gap Medical Insurance, Applied Silver Inc., Surgical Textiles, Integra LifeSciences Corporation, 3M Company, Ahlstrom-Munksjö Oyj, American Dawn Inc., Medline Industries Inc., Matguard USA, Ruhof Healthcare, BSN medical Inc., Med Pride Inc., Colorite Inc., Angelica Corporation, Hospital Specialty Company Inc., Medtronic PLC, Cramer Products Inc.

Asia-Pacific was the largest region in the antimicrobial hospital textiles market in 2023. Asia-Pacific is expected to be the fastest-growing region in the antimicrobial hospital textiles market report during the forecast period. The regions covered in the antimicrobial hospital textiles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the antimicrobial hospital textiles market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of antimicrobial hospital textiles include cotton, polyester, polyamide, and other varieties such as polyethylene, polypropylene, acrylic, and cellulose acetate. Cotton, a staple fiber composed of numerous fibers of varying lengths, is used in both disposable and reusable forms, falling under FDA class I, class II, and class III categories. These textiles are employed in various hospital departments, including general wards, surgical rooms, infectious disease wards, ICUs, and others. Their versatile applications encompass medical uniforms and apparel, upholstery, surgical textiles, incontinence care garments, wound treatment, and various other medical uses.

This report provides antimicrobial hospital textiles market statistics, including antimicrobial hospital textiles industry global market size, regional shares, competitors with an antimicrobial hospital textiles market share, detailed antimicrobial hospital textiles market segments, market trends, and opportunities, and any further data you may need to thrive in the antimicrobial hospital textiles industry. This antimicrobial hospital textiles market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antimicrobial hospital textiles market consists of sales of medical curtains, bed sheets and pillow coverings, and mattresses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.